WITHDRAWN: Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T I bladder cancer
- PMID: 26544085
- DOI: 10.1002/14651858.CD003231.pub2
WITHDRAWN: Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T I bladder cancer
Update of
-
Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.Cochrane Database Syst Rev. 2003;(3):CD003231. doi: 10.1002/14651858.CD003231. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2015 Nov 07;(11):CD003231. doi: 10.1002/14651858.CD003231.pub2. PMID: 12917955 Updated.
Similar articles
-
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer.Cochrane Database Syst Rev. 2020 Jan 8;1(1):CD011935. doi: 10.1002/14651858.CD011935.pub2. Cochrane Database Syst Rev. 2020. PMID: 31912907 Free PMC article.
-
Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.Cochrane Database Syst Rev. 2003;(3):CD003231. doi: 10.1002/14651858.CD003231. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2015 Nov 07;(11):CD003231. doi: 10.1002/14651858.CD003231.pub2. PMID: 12917955 Updated.
-
Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.Semin Urol Oncol. 1996 Feb;14(1 Suppl 1):10-6. Semin Urol Oncol. 1996. PMID: 8727805 Clinical Trial.
-
Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993).Eur Urol. 2011 Mar;59(3):438-46. doi: 10.1016/j.eururo.2010.11.038. Epub 2010 Dec 7. Eur Urol. 2011. PMID: 21156335 Clinical Trial.
-
Intravesical electromotive drug administration for non-muscle invasive bladder cancer.Cochrane Database Syst Rev. 2017 Sep 12;9(9):CD011864. doi: 10.1002/14651858.CD011864.pub2. Cochrane Database Syst Rev. 2017. PMID: 28898400 Free PMC article.
Cited by
-
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer.Cochrane Database Syst Rev. 2020 Jan 8;1(1):CD011935. doi: 10.1002/14651858.CD011935.pub2. Cochrane Database Syst Rev. 2020. PMID: 31912907 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical